Altre lingue Clarivate Plc

Azioni

CLVT

JE00BJJN4441

Servizi di informazione professionale

Mercato chiuso - Nyse Altri mercati azionari 22:00:02 17/01/2025			Variaz. 5gg	Var. 1 gen.
5,090 ^USD	0,00%		0,00%	+0,20%

14/01	Clarivate plc lancia Drg Fusion - un nuovo prodotto di analisi delle scienze della vita alimentato da dati del mondo reale	CI
16/12	Clarivate approva un piano di riacquisto di azioni fino a 500 milioni di dollari	MT

Altre lingue

BioWorld by Clarivate Releases Comprehensive 2024 Year in Review	16/01
Clarivate : Launches DRG Fusion A New Life Sciences Analytics Product Powered by Real World Data	14/01
Clarivate Launches DRG Fusion - A New Life Sciences Analytics Product Powered by Real-World Data	14/01
Clarivate plc Launches Drg Fusion - A New Life Sciences Analytics Product Powered by Real-World Data	14/01
Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report	08/01
Clarivate : Annual Report Released by Clarivate, the Chinese Academy of Engineering and the Higher Education Press of China Identifies 184 Engineering Fronts	18/12
Clarivate : Murata Selects IPfolio from Clarivate	17/12
Clarivate Approves Up to $500 Million Share Buyback Plan	16/12
Clarivate Plc announces an Equity Buyback for $500 million worth of its shares.	16/12
Clarivate Plc authorizes a Buyback Plan.	16/12
Clarivate plc Announces Retirement of Richard Roedel from the Board of Directors, Effective January 1, 2025	13/12
Clarivate Launches AI-Powered Patent Search Solution in Derwent	12/12
Clarivate : and the Chinese Academy of Sciences Release Annual Collaborative Report to Identify 125 Research Fronts	27/11
Daikin Selects IPfolio from Clarivate	27/11
Clarivate Insider Bought Shares Worth $17,863,350, According to a Recent SEC Filing	25/11
BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series	21/11
Clarivate Reveals Highly Cited Researchers 2024 List	19/11
New Report from Clarivate and Healthcare Executive Explores Mainland China's Biopharma Revolution and Increasing Global Influence	18/11
Clarivate Healthcare Business Insights Unveils 2023 Revenue Cycle Award Winners	13/11
Clarivate Publishes 2023 Sustainability Report	12/11
America's right swipe reignites the bull market	07/11
Analyst recommendations: Corteva, Dollar Tree, JPMorgan, Microsoft, Palantir...	07/11
Clarivate Launches New Sustainability Research Solution	07/11
Clarivate's Q3 Adjusted Earnings, Revenue Fall; 2024 Guidance Withdrawn	06/11
Clarivate : Reports Third Quarter 2024 Results Form 8 K	06/11

Iscriviti per accedere a più notizie

Registrazione 100% gratuita

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Clarivate Plc

Azioni

CLVT

JE00BJJN4441

Servizi di informazione professionale

Altre lingue

Filtri